BIOCRYST PHARMACEUTICALS INC 4

Accession 0000882796-06-000014

$BCRXCIK 0000882796operating

View on SEC.gov Company Profile

Filed

Mar 16, 7:00 PM ET

Accepted

Mar 17, 1:03 PM ET

Size

60.3 KB

Accession

0000882796-06-000014

Insider Transaction Report

Form 4

Period: 2006-03-15

BIOCRYST PHARMACEUTICALS INCBCRX

DARWIN MICHAEL A

Chief Financial Officer

Transactions

Sale
Common Stock
2006-03-15$19.00/sh−1,983$37,677→ 21,335 total
Exercise/Conversion
Emp. Stock Option (right to buy)
2006-03-15$6.09/sh−3,800$23,157→ 0 total
Exercise: $6.09From: 2002-03-23Exp: 2011-03-23→ Common Stock (3,800 underlying)
Exercise/Conversion
Common Stock
2006-03-15$0.87/sh+7,350$6,395→ 8,018 total
Exercise/Conversion
Emp. Stock Option (right to buy)
2006-03-15$1.18/sh−6,000$7,080→ 700 total
Exercise: $1.18From: 2003-08-05Exp: 2012-08-05→ Common Stock (6,000 underlying)
Sale
Common Stock
2006-03-15$19.08/sh−200$3,816→ 18,251 total
Sale
Common Stock
2006-03-15$19.15/sh−4,500$86,175→ 12,014 total
Sale
Common Stock
2006-03-15$19.02/sh−700$13,314→ 20,035 total
Exercise/Conversion
Common Stock
2006-03-15$3.59/sh+3,700$13,283→ 17,718 total
Sale
Common Stock
2006-03-15$19.03/sh−100$1,903→ 19,935 total
Sale
Common Stock
2006-03-15$19.05/sh−471$8,973→ 19,364 total
Exercise/Conversion
Emp. Stock Option (right to buy)
2006-03-15$3.59/sh−3,700$13,283→ 0 total
Exercise: $3.59From: 2002-12-12Exp: 2011-12-12→ Common Stock (3,700 underlying)
Exercise/Conversion
Common Stock
2006-03-15$8.88/sh+1,800$15,975→ 23,318 total
Sale
Common Stock
2006-03-15$19.01/sh−600$11,406→ 20,735 total
Sale
Common Stock
2006-03-15$19.34/sh−800$15,472→ 4,668 total
Gift
Common Stock
2006-03-15$21.00/sh−668$14,028→ 0 total
Exercise/Conversion
Emp. Stock Option (right to buy)
2006-03-15$0.87/sh−7,350$6,395→ 3,403 total
Exercise: $0.87From: 2004-02-03Exp: 2013-02-03→ Common Stock (7,350 underlying)
Exercise/Conversion
Emp. Stock Option (right to buy)
2006-03-15$8.88/sh−1,800$15,975→ 0 total
Exercise: $8.88From: 2001-12-12Exp: 2010-12-12→ Common Stock (1,800 underlying)
Exercise/Conversion
Common Stock
2006-03-15$6.09/sh+3,800$23,157→ 21,518 total
Sale
Common Stock
2006-03-15$19.10/sh−1,737$33,177→ 16,514 total
Exercise/Conversion
Common Stock
2006-03-15$1.18/sh+6,000$7,080→ 14,018 total
Sale
Common Stock
2006-03-15$19.30/sh−4,946$95,458→ 6,568 total
Sale
Common Stock
2006-03-15$19.35/sh−1,700$32,895→ 2,968 total
Sale
Common Stock
2006-03-15$19.31/sh−400$7,724→ 6,168 total
Sale
Common Stock
2006-03-15$19.06/sh−913$17,402→ 18,451 total
Sale
Common Stock
2006-03-15$19.25/sh−300$5,775→ 11,514 total

Footnotes (3)

[F1]Sale of stock is pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934
[F2]Voluntary disclosure of gift of 668 shares to a charitable organization on 2/27/06
[F3]Exercise pursuant to 10b5-1 rule of the Securities Exchange Act of 1934

Documents

1 file

4
doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000882796

Filing Metadata

Form type: 4
Filed: Mar 16, 7:00 PM ET
Accepted: Mar 17, 1:03 PM ET
Size: 60.3 KB

View on SEC.gov